Emerging Treatment Options for Patients With Kidney Cancer

James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan-Kettering Cancer Center, discusses emerging treatment options for patients with kidney cancer.

Clinical Pearls

James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan-Kettering Cancer Center, discusses emerging treatment options for patients with kidney cancer.

  • New emerging treatment options are all trial-based
  • There are newer antiangiogenic agents that are just as efficacious but generate less toxicity
  • Researchers and oncologists are excited about immunotherapy for the treatment of kidney cancer
  • New immunotherapies are similar to interleukin-2 and interferon but are more effective, more specific, and less toxic